Hyderabad Telangana, India

Joydeep Mazumder

This inventor holds 1 USPTO granted patent. Top assignee: Dr. Reddy's Laboratories, Incorporated. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joydeep Mazumder. Retrieved from https://idiyas.com/inventor/joydeep-mazumder

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joydeep Mazumder: Innovator in Pharmaceutical Formulations

Introduction

Joydeep Mazumder is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable liquid formulations for cancer treatment.

Latest Patents

Joydeep holds a patent for "Stable liquid formulations of cyclophosphamide and its impurities." This invention relates to novel impurities of cyclophosphamide, specifically structures V, VI, or VII. It includes a stabilized form of these impurities, a process for preparing and isolating them, and formulations that incorporate cyclophosphamide along with at least one pharmaceutically acceptable excipient. The invention also details methods for using these stable liquid formulations for parenteral administration in treating various cancer disorders.

Career Highlights

Joydeep is currently employed at Dr. Reddy's Laboratories, Incorporated, where he continues to innovate in the pharmaceutical sector. His work focuses on enhancing the efficacy and safety of cancer treatments through advanced formulation techniques.

Collaborations

Joydeep collaborates with talented professionals such as Riyaz Ahmed Shaik and Ananya Saha, contributing to a dynamic research environment that fosters innovation.

Conclusion

Joydeep Mazumder's work exemplifies the intersection of innovation and healthcare, particularly in the development of effective cancer therapies. His contributions are vital in advancing pharmaceutical formulations that improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…